WO2007092930A3 - Method of treatment for mycobacterium tuberculosis - Google Patents

Method of treatment for mycobacterium tuberculosis Download PDF

Info

Publication number
WO2007092930A3
WO2007092930A3 PCT/US2007/061859 US2007061859W WO2007092930A3 WO 2007092930 A3 WO2007092930 A3 WO 2007092930A3 US 2007061859 W US2007061859 W US 2007061859W WO 2007092930 A3 WO2007092930 A3 WO 2007092930A3
Authority
WO
WIPO (PCT)
Prior art keywords
mycobacterium tuberculosis
treatment
administering
subject
pharmaceutically acceptable
Prior art date
Application number
PCT/US2007/061859
Other languages
French (fr)
Other versions
WO2007092930A2 (en
Inventor
Shiou-Chuan Tsai
Pierre F Baldi
Original Assignee
Univ California
Shiou-Chuan Tsai
Pierre F Baldi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Shiou-Chuan Tsai, Pierre F Baldi filed Critical Univ California
Publication of WO2007092930A2 publication Critical patent/WO2007092930A2/en
Publication of WO2007092930A3 publication Critical patent/WO2007092930A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/655Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds

Abstract

A method for treating Mycobacterium tuberculosis infections in a subject in need thereof comprising administering a naphthylamine sulfonate derivative or a pharmaceutically acceptable salt thereof.
PCT/US2007/061859 2006-02-08 2007-02-08 Method of treatment for mycobacterium tuberculosis WO2007092930A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77149406P 2006-02-08 2006-02-08
US60/771,494 2006-02-08

Publications (2)

Publication Number Publication Date
WO2007092930A2 WO2007092930A2 (en) 2007-08-16
WO2007092930A3 true WO2007092930A3 (en) 2007-12-13

Family

ID=38345957

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/061859 WO2007092930A2 (en) 2006-02-08 2007-02-08 Method of treatment for mycobacterium tuberculosis

Country Status (1)

Country Link
WO (1) WO2007092930A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4827986B2 (en) 2007-06-08 2011-11-30 マンカインド コーポレ−ション IRE-1α inhibitor
WO2009091324A1 (en) * 2008-01-14 2009-07-23 Jyoti Chattopadhyaya Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivates as anti-mycobacterial agents

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3285905A (en) * 1963-08-30 1966-11-15 Parke Davis & Co 1-{3-{[5, 6, 7, 8-tetrahydro-4-(arylazo)-1-naphthyl]amino}propyl}piperidine compounds
US5231170A (en) * 1986-08-27 1993-07-27 Paul Averback Antibodies to dense microspheres
US20040131568A1 (en) * 2002-01-29 2004-07-08 Hwang Cheng Shine Reduction of hair growth

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3285905A (en) * 1963-08-30 1966-11-15 Parke Davis & Co 1-{3-{[5, 6, 7, 8-tetrahydro-4-(arylazo)-1-naphthyl]amino}propyl}piperidine compounds
US5231170A (en) * 1986-08-27 1993-07-27 Paul Averback Antibodies to dense microspheres
US20040131568A1 (en) * 2002-01-29 2004-07-08 Hwang Cheng Shine Reduction of hair growth

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GAGO G. ET AL.: "Biochemical and structural characterization of an essential acyl coenzyme A carboxylase from Mycobacterium tuberculosis", JOURNAL OF BACTERIOLOGY, vol. 188, no. 2, June 2006 (2006-06-01), pages 477 - 486, XP008091424 *

Also Published As

Publication number Publication date
WO2007092930A2 (en) 2007-08-16

Similar Documents

Publication Publication Date Title
WO2007087395A3 (en) UNSATURATED mTOR INHIBITORS
IL186452A0 (en) Methods and means for diagnostics, prevention and treatment of mycobacterium infections and tuberculosis disease
AP2327A (en) Quinoline derivatives for the treatment of latent tuberculosis.
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
WO2007087468A3 (en) Adiponectin for treatment of various disorders
WO2007034188A3 (en) Chemo-immunotherapy method
WO2007087431A3 (en) Sublingual fentanyl spray
WO2007106537A3 (en) Aminoquinolones as gsk-3 inhibitors
AU2005209854A1 (en) Method of treating hemolytic disease
IL192150A0 (en) Therapeutic agent for inflammatory bowel disease containing as active ingredient 2-amino-1,3-propanediol derivative, or method for treating inflammatory bowel disease
WO2008137237A3 (en) Method for forming crystallized therapeutic agents on a medical device
WO2007087204A3 (en) Heterocycles as nicotinic acid receptor agonists for the treatment of dyyslipidemia
IL196697A (en) Use of 4-hydroxy-alpha-phenyl butyl nitrone or its derivatives for the preparation of a medicament for treating sensorineural hearing loss
WO2007118130A3 (en) Antibacterial agents
WO2009035634A3 (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors
WO2007140317A3 (en) Use of inhibitors of cytosolic ph0sph0lipase a2 in the treatment of thrombosis
EA201000039A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING SOLIFENACIN OR ITS PHARMACEUTICALLY ADAPTABLE SALT
WO2008070010A3 (en) Hydroxylamine derivatives for the treatment of stroke
WO2008071961A8 (en) 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents
TW200733963A (en) Cough inhibitor
WO2008057196A3 (en) Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases
TNSN07038A1 (en) Methods for improving bioavailability of a renin inhibitor
WO2008063847A3 (en) Method for treating autism
WO2007092930A3 (en) Method of treatment for mycobacterium tuberculosis
MX2008010804A (en) Rapamycin derivatives for treating neuroblastoma.

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07763518

Country of ref document: EP

Kind code of ref document: A2